Filing metadata

Accession number
0001104659-22-007841
Form type
Form 4
Filer
RVL Pharmaceuticals plc
CIK
CIK 1739426
Filed
Jan 26, 2022
Reporting period
Jan 24, 2022
Description
Insider transaction

Explore SEC Filings Hub